Anti-Retroviral Therapy (ART)

Feb. 28, 2025

The Supreme Court recently directed all States to respond to concerns relating to periodic stockouts, transparency in tendering and procurement, and drug quality and certification processes of the of Anti-Retroviral Therapy (ART) drugs for People Living with HIV/AIDS (PLHIV).

About Anti-Retroviral Therapy (ART):

  • ART is a combination of medications that treat human immunodeficiency virus (HIV).
    • HIV is a virus that destroys CD4 cells (also called helper T-cells), an important part of the immune system.
  • While ART cannot cure HIV, prompt HIV treatment can help all people with HIV live long, healthy lives and reduce the risk of HIV transmission.
  • Although there may still be HIV in the body, the additional CD4 cells keep the immune system strong enough to fight off infections.
  • By reducing the amount of HIV in the body, HIV medicines also reduce the risk of HIV transmission.
  • One of the main goals of HIV treatment is to reduce a person’s viral load to an undetectable level.
    • People with HIV who maintain an undetectable viral load have effectively no risk of transmitting HIV through physical relationship, and a significantly lower risk of transmission through other means (such as shared needles).
  • It is a combination of medications. Taking a combination of medications, rather than just one, makes the treatment more effective.
  • HIV treatment is called “antiretroviral” because HIV is a retrovirus.
    • This means it uses its genetic material (RNA) as a template to make DNA.
  • Types of ART medications include:
    • Entry inhibitors. These include attachment inhibitors, fusion inhibitors, CCR5 antagonists and post-attachment inhibitors.
    • Capsid inhibitors
    • Nucleoside reverse transcriptase inhibitors (NRTIs)
    • Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
    • Integrase inhibitors/integrase strand transfer inhibitors (INSTIs)
    • Protease inhibitors
    • Pharmacokinetic enhancers
    • Combination medications

Latest Current Affairs

See All

Enquire Now